| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-270 |
| PharmacoGx | KIN001-270 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRDM15 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | ZFP69B | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | MDN1 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | IGLL5 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | RASGEF1B | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | ILF3 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | PRKAR2B | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | SIRT1 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | NQO1 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-06 |
| mRNA | CDCA8 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
